Metabolic telehealth program · United States

Basal

Basal runs a clinician-supervised metabolic care program built around compounded tirzepatide, diagnostics and ongoing clinical oversight for patients in the US.

About Basal

A metabolism-first telehealth program

Basal Health, LLC operates GLP-One, a physician-supervised metabolic care program that combines GLP-1 therapy with tirzepatide, diagnostics and continuing clinical oversight. The company was co-founded by Lori Allred and Darin Allred, MD, and frames its approach as managing the metabolic environment the medication enters rather than prescribing a single molecule. Treatment is prescribed by licensed clinicians after an intake assessment; the company states that approval is not automatic and that prescriptions are issued only when clinically appropriate.

How GLP-One works

  • Eligibility screening and clinician review: an intake form supplies the clinical data used to decide whether GLP-1 therapy is suitable.
  • Personalized tirzepatide treatment: the starting dose and titration schedule are set according to the patient's goals and biology.
  • Ongoing adaptive care: progress is monitored and dosage adjusted through regular check-ins.
  • Metabolic literacy: easy-to-consume education and personalized clinician counselling accompany the prescription.

Two plans are offered: a Microdose plan oriented to restoring metabolic health and a Weightloss plan. The compounded medication is prepared in licensed pharmacies in the United States, and the company notes that product images are renderings and that the appearance of the medication may vary depending on the compounding pharmacy partner.

Pricing and billing

Tirzepatide starts at $149 for the first four weeks and then $299 every four weeks. The price is the same at every dose and no membership fee is charged. Billing runs every four weeks, and the patient is not charged until a licensed clinician approves the treatment.

The five metabolic markers

The program tracks five signals it presents as predictors of long-term health: insulin sensitivity, muscle mass, hormonal response, VO2 max and body fat percentage. These markers are used to follow how the body responds to treatment and to tailor the protocol. Alongside medication, clinicians prescribe lifestyle changes.

Coverage and credentials

Basal serves patients in all 50 U.S. states and the District of Columbia. The company states that it works with advanced laboratories and medical-grade systems for diagnostics and holds LegitScript certification. It also publishes patient testimonials describing experiences with GLP-1 treatment.

In brief

Clinician-supervised GLP-1 metabolic care with tirzepatide